Afimetoran
- Generic Name
- Afimetoran
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C26H32N6O
- CAS Number
- 2171019-55-7
- Unique Ingredient Identifier
- LXP7MZL0VF
- Background
Afimetoran is an immunomodulator and an antagonist of toll-like receptors 7 and 8. It is also is under investigation in clinical trial NCT04269356 (Study to Assess the Way the Body Absorbs, Distributes, Breaks Down and Eliminates Radioactive BMS-986256 in Healthy Male Participants).
- Associated Conditions
- -
- Associated Therapies
- -
An Investigational Study to Evaluate the Effects of Experimental Medication BMS-986256 in Healthy Participants
- First Posted Date
- 2018-08-17
- Last Posted Date
- 2020-06-16
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 118
- Registration Number
- NCT03634995
- Locations
- 🇺🇸
Anaheim Clinical Trials, Anaheim, California, United States
🇺🇸PRA Health Science KK, Lenexa, Kansas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath